R&D How AI simulation could help de-risk obesity and cardiometab... AI life sciences models allow researchers to explore different patient populations, protocols, and development strategies before a study starts.
Patients The cardio-renal-metabolic space and obesity as a chronic di... The podcast welcomes Dr Ramy Younes, corporate VP, global head of clinical development, cardiorenalmetabolism, at Boehringer Ingelheim.
News Roche adds another obesity drug with $1.16bn Rona deal Roche has added to its weight-loss drug pipeline again, turning to China's Rona Therapeutics for an RNAi candidate targeting ALK7.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.